OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
19.35
+0.53 (2.82%)
Oct 23, 2025, 10:59 AM EDT - Market open
OptimizeRx Revenue
OptimizeRx had revenue of $29.20M in the quarter ending June 30, 2025, with 55.19% growth. This brings the company's revenue in the last twelve months to $104.75M, up 25.89% year-over-year. In the year 2024, OptimizeRx had annual revenue of $92.13M with 28.81% growth.
Revenue (ttm)
$104.75M
Revenue Growth
+25.89%
P/S Ratio
3.31
Revenue / Employee
$812,000
Employees
129
Market Cap
359.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 92.13M | 20.61M | 28.81% |
| Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
| Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
| Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
| Dec 31, 2020 | 43.31M | 18.72M | 76.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OPRX News
- 3 days ago - OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET - GlobeNewsWire
- 14 days ago - 4 Top AI-Powered Healthcare Stocks - Seeking Alpha
- 15 days ago - OptimizeRx: How The Stock Is Changing Pharma Marketing - Seeking Alpha
- 6 weeks ago - OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference - GlobeNewsWire
- 6 weeks ago - OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising - GlobeNewsWire
- 2 months ago - OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth - GlobeNewsWire
- 2 months ago - OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - GlobeNewsWire